Domenic G Iezzoni

US Patent:

6423721, Jul 23, 2002

Filed:

Sep 9, 1999

Appl. No.:

09/391795

Inventors:

Alan G. Harris - New York NY
Domenic G. Iezzoni - Ridgewood NJ
Melvyn R. Danzig - Morganville NJ
Richard R. Lorber - Scotch Plains NJ

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A61K 3144

US Classification:

514290

Abstract:

The present invention discloses antibiotic-excluded compositions and methods to treat non-infective sinusitis and/or otitis media. The compositions comprise a therapeutically effective amount of an anticholinergic antihistamine or a pharmaceutically acceptable salt or solvate thereof; and (ii) a pharmaceutically acceptable carrier, and the methods comprise administering the same.

US Patent:

62654144, Jul 24, 2001

Filed:

May 3, 2000

Appl. No.:

9/563553

Inventors:

Alan G. Harris - New York NY
Domenic G. Iezzoni - Ridgewood NJ

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A61K 314375

US Classification:

514290

Abstract:

Methods of treating and/or preventing sleep disorders in a human afflicted with upper airway passage allergic inflammation and/or congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis, by administering a therapeutically effective amount of desloratadine, alone or in combination with other active such as a decongestant, e. g. , pseudoephedrine are disclosed.

US Patent:

61143464, Sep 5, 2000

Filed:

Oct 22, 1999

Appl. No.:

9/425715

Inventors:

Alan G. Harris - New York NY
Domenic G. Iezzoni - Ridgewood NJ

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A61K 31435

US Classification:

514290

Abstract:

Methods of treating and/or preventing sleep disorders in a human afflicted with upper airway passage allergic inflammation and/or congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis by administering a therapeutically effective amount of desloratadine, alone or in combination with other active agents such as a decongestant as pseudoephedrine are disclosed.

US Patent:

61403377, Oct 31, 2000

Filed:

Aug 20, 1999

Appl. No.:

9/378303

Inventors:

Gary Binder - Westfield NJ
Domenic G. Iezzoni - Ridgewood NJ
William Kreutner - West Paterson NJ
Arnold Lash - Branchburg NJ

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A61K 31435
A61K 314545

US Classification:

514290

Abstract:

The present invention provides methods of treatment of mental disorders comprising administering the anti-allergic medication loratadine or a metabolite thereof to reduce a patient's symptoms of a mental disorder.